Avalon Pharmaceuticals Financial Statements
Avalon Pharmaceuticals Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Avalon Pharmaceuticals Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.3 | 0.8 | 2.7 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | (21.8) | (21.7) | (17.1) |
| Diluted EPS (Net Income) | (1.24) | (1.42) | (1.74) |
Avalon Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 41.84 | 4.84 | 7.01 |
| Price/Earnings Ratio | (0.57) | (52.08) | 25.51 |
| Price/Book Ratio | 9.35 | 4.40 | 6.74 |
| Price/Cash Flow Ratio | (0.64) | 38.31 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Avalon Pharmaceuticals Financial Ratios
